{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"117.800","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"78,707,270","primaryexch":"香港交易所","ric":"2637.HK","product_subtype":null,"db_updatetime":"2025年10月20日09:36","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BVBQP75","am":"204.21","iv":"","ew_strike":"","as":"109.600","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"109.500","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"50","update_time":"2025-10-20 01:36:28.0","lo52":"","shares_issued_date":"2025年10月20日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"康心汕","underlying_ric":"2637.HK","hi52":"","issuer_name":"福建海西新藥創制股份有限公司 - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年10月20日10:21","aum_date":"","lo":"100.000","mkt_cap":"8.61","f_aum_hkd":null,"ew_sub_per_to":"","ls":"109.500","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"1.78","secondary_listing_flag":false,"listing_date":"2025年10月20日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"福建海西新藥創制股份有限公司 - H股","nm_s":"海西新藥","sym":"2637","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.100","strike_price":"","summary":"福建海西新藥創制股份有限公司是一家主要從事仿制藥和創新藥研發、生産及銷售的中國公司。該公司的主要産品包括安必力、海慧通、瑞安妥、賽西福。該公司的産品主要用于消化系統疾病、心血管系統疾病、內分泌系統疾病、神經系統疾病、炎症疾病、癌症、眼科及呼吸系統疾病等。該公司主要在中國國內開展業務。","op":"102.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國福建省<br/>福州市倉山區<br/>建新鎮金達路177號<br/>B座三樓、四樓","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE100007515","moneyness":""}},"qid":"1760927786006"}
